Home » Newsletters » BioWorld MedTech

BioWorld MedTech

May 13, 2014

View Archived Issues

Cyberonics gains positive results from PuLsE post approval study

Deals: Allergan says Valeant proposal not in best interest of company

Financings: InVivo Therapeutics closes underwritten public offering

Products

Patent Watch: Sanuwave receives patent for sterilization with shock waves

World in Review: Foundation Medicine obtains CE mark for FoundationOne

People in Places

MDD's Cardiology Extra

Heart Rhythm Society 2014: HRS: DoJ, CMS both aware of off-guideline document for ICD

Abbott study shows promising data for new testing platform

Today's news in brief
BioWorld
BioWorld briefs for Dec. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 27, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Probing bidirectional cancer-autoimmune link can yield new targets
BioWorld Science
Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.